CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages

Information

• Research Project
• 9552956

• ApplicationId

  9552956

• Core Project Number

  R44CA206788

• Full Project Number

  4R44CA206788-02

• Serial Number

  206788

• FOA Number

  PA-15-269

• Sub Project Id

• Project Start Date

  5/27/2016 - 8 years ago

• Project End Date

  8/31/2019 - 5 years ago

• Program Officer Name

  EVANS, GREGORY

• Budget Start Date

  9/14/2017 - 7 years ago

• Budget End Date

  8/31/2018 - 6 years ago

• Fiscal Year

  2017

• Support Year

  02

• Suffix

• Award Notice Date

  9/14/2017 - 7 years ago

Organizations

• Neoprobe Corporation

IC Name

• Activity

  R44

• Administering IC

  CA

• Application Type

  4

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  939552

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  395

• Ed Inst. Type

• Funding ICs

  NCI:939552\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  NAVIDEA BIOPHARMACEUTICALS, INC.

• Organization Department

• Organization DUNS

  131891467

• Organization City

  DUBLIN

• Organization State

  OH

• Organization Country

  UNITED STATES

• Organization Zip Code

  43017

• Organization District

  UNITED STATES